| 翻訳と辞書 |
| Global HIV Vaccine Enterprise ： ウィキペディア英語版 |
Global HIV Vaccine Enterprise
thumb
The Global HIV Vaccine Enterprise (the Enterprise) is an alliance of organizations formed to accelerate the search for an HIV vaccine. Initially proposed in Science magazine in 2003 〔 and developed by scientists, health experts and policy makers, the concept of the Enterprise received support from the G8 the following year. The primary aim of the organization is to provide leadership in efforts to reverse the AIDS epidemic. The organization, based in New York City, was founded by representatives from The Gates Foundation, NIH, WHO-UNAIDS, European Commission, Wellcome Trust Wellcome Trust, International AIDS Vaccine Initiative, French National Agency for Research on AIDS and Viral Hepatitis.
== History ==
In June 2003, a group of 24 individuals in the field of HIV vaccines published a Policy Forum article in the journal Science 〔 proposing the creation of the Global HIV Vaccine Enterprise. The article asserted that current attempts to develop such a vaccine were insufficient and that a renewed HIV vaccine research effort was required. The G8 pledged support in July 2004 and the following year, the Enterprise published the Scientific Strategic Plan in the journal PLoS Medicine.〔Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise (2005) The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan. PLoS Med 2(2): e25. 18 January 2005〕 The activities of the organization are managed by a Secretariat, overseen by a Board of Directors and advised by the Enterprise Council and a Science Committee.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Global HIV Vaccine Enterprise」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|
